Pfizer Stocks Plummet as RFK Jr.'s Health Secretary Appointment Rocks Vaccine Market
Friday, 15 November 2024, 15:23
Market Reaction to RFK Jr.'s Appointment
The announcement of RFK Jr. as the next Secretary of Health and Human Services has sent shockwaves through the vaccine stocks market. Investors are wary of potential policy shifts and their implications for public health initiatives and corporate profits.
Vaccine Stocks Face Decline
- BioNTech (NASDAQ: BNTX) saw a staggering drop of 11.02% in after-hours trading.
- Novavax (NASDAQ: NVAX) followed closely with an 8.66% loss, reflecting escalating concerns.
- Moderna (NASDAQ: MRNA) reported a decline of 6.61%, showcasing the widespread market anxiety.
Interestingly, Pfizer (NYSE: PFE), known for its pivotal role in COVID-19 vaccinations, experienced a lesser decline of 4.4%. However, this still raises questions about its competitive edge in the new political landscape.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.